Estadísticas de Angiotensin-converting-enzyme inhibitors and angiotensin II re-ceptor blockers for COVID-19: A living systematic review of randomized clinical trials

Visitas totales

views
Angiotensin-converting-enzyme inhibitors and angiotensin II re-ceptor blockers for COVID-19: A living systematic review of randomized clinical trials 2

Visitas totales por mes

views
June 2025 0
July 2025 0
August 2025 0
September 2025 0
October 2025 0
November 2025 1
December 2025 0

Visitas de archivo

views
Meza_Angi2021.pdf 43